*Some Market data delayed by 15 mins.

Merus N.V. Common Shares

Symbol: MRUS (NASDAQ)
56.12 ▼ (-0.75%) -0.426

Company Description:
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Key Stats
  • Today's Open: $56.59
  • Today's High: $58.3
  • Today's Low: $54.831
  • Today's Volume: 709.41K
  • Yesterday Close: $56.55
  • Yesterday High: $58.15
  • Yesterday Low: $55.28
  • Yesterday Volume: 565.10K
  • Last Min Volume: 0
  • Last Min High: $56.124
  • Last Min Low: $56.119
  • Last Min VWAP: $0
Company Profile
  • Name: Merus N.V. Common Shares
  • Website: https://www.merus.nl
  • Listed Date: 2016-05-19
  • Location: 3584 CM UTRECHT, P7
  • Market Status: Active
  • CIK Number: 0001651311
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $3.76B
  • Round Lot: 100
  • Outstanding Shares: 67.37M
  • Asset Type: CS
RECENT FILINGS FOR MRUS
Filing DateFiling TypeFormat
2024-06-17144View
2024-06-124View
2024-06-064View
2024-05-308-KView
2024-05-30424B5View
2024-05-28424B5View
2024-05-288-KView
2024-05-108-K/AView
2024-05-10UPLOADView
2024-05-094View
2024-05-094View
2024-05-094View
2024-05-093View
2024-05-094View
2024-05-094View
2024-05-094View
2024-05-094View
2024-05-094View
2024-05-094View
2024-05-094View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.